TORONTO, June 08, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) (“Field Trip”), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has applied to list its common shares (the “Common Shares”) on the NASDAQ Stock Market (“NASDAQ”). “Psychedelics stand poised to disrupt modern psychiatry, and the NASDAQ is where world…


Previous articlePT247 – Julian Vayne – Magic, Prohibition, and New Models for Legality
Next articleAwakn Life Sciences Completes Previously Announced Private Placement For Gross Proceeds Of $8.3 Million